RCC2 play an oncogenic role by promoting proliferation and migration of DDP-resistant ovarian cancer cell lines and inhibiting cell apoptosis by regulating RalA signaling pathway (Gong et al., 2019). The gene discussed is RCC2; the disease is ovarian cancer.